Changzheng Li
Xinxiang, 453003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Lactylation in metabolic dysfunction-associated steatotic liver disease: epigenetic regulatory mechanisms and potential therapeutic strategies.
Journal: Biochemical pharmacology
Published: March 30, 2026
Induction of paraptotic cell death in breast cancer cells by an iron chelator involved activation of UPR/MAPK pathway and inactivation of PI3K/AKT/mTOR.
Journal: Scientific reports
Published: January 22, 2026
Mechanism and interventions of the bile acid-gut-liver axis imbalance in the progression of non-alcoholic fatty liver disease.
Journal: Biochemical pharmacology
Published: January 01, 2026
NCOA4-mediated ferroptosis conducive to EMT inhibition in colorectal cancer cells was achieved through the PI3K/AKT/mTOR pathway.
Journal: Scientific reports
Published: March 30, 2025
Floralozone attenuates atherosclerotic vascular injury by regulating AMPKα/SREBP-1c pathway and down-regulating miR-33-5p.
Journal: European journal of nutrition
Published: October 29, 2024
A new metal ion chelator attenuates human tau accumulation-induced neurodegeneration and memory deficits in mice.
Journal: Experimental neurology
Published: November 14, 2023
The interaction between lipocalin 2 and dipyridine ketone hydrazone dithiocarbamte may influence respective function in proliferation and metastasis-related gene expressions in HepG2 cell.
Journal: Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry
Published: September 06, 2020
Gastroprotective and anti-ulcer effects of oxymatrine against several gastric ulcer models in rats: Possible roles of antioxidant, antiinflammatory, and prosurvival mechanisms.
Journal: Phytotherapy research : PTR
Published: April 07, 2018
The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling.
Journal: Scientific reports
Published: September 05, 2017
Synergistic anti-tumor activity of Nimotuzumab in combination with Trastuzumab in HER2-positive breast cancer.
Journal: Biochemical and biophysical research communications
Published: April 30, 2017
Correction: Zhongjie Xu, et al. Analysis of the Interaction of Dp44mT with Human Serum Albumin and Calf Thymus DNA using Molecular Docking and Spectroscopic Techniques. Int. J. Mol. Sci. 2016, 17, 1042.
Journal: International journal of molecular sciences
Published: September 28, 2016
Last Updated: 09/26/2026